| |
LM initiation |
3 months† N=23 |
6 months‡ N=20 |
| |
CD4 count |
CD4% |
CD4 count |
CD4 % |
CD4 count |
CD4 % |
| 1 |
520 |
18 |
347 |
14.2 |
|
|
| 2 |
1512 |
35.4 |
1540 |
36.8 |
1355 |
30.4 |
| 3 |
627 |
19.65 |
610 |
22.3 |
|
|
| 4 |
534 |
26.2 |
476 |
19.3 |
358 |
15.6 |
| 5 |
1984 |
32.1 |
1648 |
31.3 |
1462 |
33.6 |
| 6 |
527 |
25.4 |
569 |
24.6 |
549 |
22.5 |
| 7 |
578 |
29.4 |
380 |
24 |
447 |
23.2 |
| 8 |
500 |
30.6 |
546 |
29.7 |
755 |
30.4 |
| 9 |
84 |
3.4 |
8 |
0.58 |
Stopped LM after 5 months |
| 10 |
475 |
11.2 |
244 |
10 |
123 |
3.8 |
| 11 |
994 |
41.5 |
759 |
30.2 |
761 |
30.4 |
| 12 |
341 |
10.8 |
316 |
13.6 |
Stopped LM after 4 months |
| 13 |
547 |
16.3 |
425 |
14.7 |
478 |
15.3 |
| 14 |
895 |
21.53 |
1188 |
13.09 |
748 |
17.43 |
| 15 |
1745 |
14.69 |
|
|
1066 |
16.35 |
| 16 |
1730 |
25.36 |
1101 |
30 |
1166 |
29.94 |
| 17 |
1005 |
34.35 |
371 |
28.54 |
186 |
13.52 |
| 18 |
752 |
28.96 |
752 |
28.9 |
540 |
23.89 |
| 19 |
1239 |
19.8 |
|
Defaulted follow-up after 3 months |
| 20 |
982 |
17.9 |
|
|
872 |
19.41 |
| 21 |
285 |
18.4 |
|
|
285 |
19.8 |
| 22 |
1632 |
33.7 |
478 |
16.6 |
1136 |
22.7 |
| 23 |
715 |
34.8 |
477 |
29.2 |
649 |
31.6 |
* LM = Lamivudine monotherapy
† 4/23 did not have a CD4 measure performed at 3 months of follow-up.
‡ 2/20 who remained on LM at 6 months did not have a CD4 measure performed. |
